

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 5.13141335 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.13141335 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.90645416 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 4.88133715 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 4.88133715 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.88133715 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.88133715 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.88133715 |
| 9 | modulation by symbiont of host immune response (GO:0052553) | 4.88133715 |
| 10 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.41779659 |
| 11 | negative regulation of interleukin-12 production (GO:0032695) | 4.07147094 |
| 12 | macrophage activation involved in immune response (GO:0002281) | 4.02285274 |
| 13 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.00166529 |
| 14 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.99516204 |
| 15 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.96737215 |
| 16 | microglial cell activation (GO:0001774) | 3.87502100 |
| 17 | neutrophil activation involved in immune response (GO:0002283) | 3.87380026 |
| 18 | myeloid cell activation involved in immune response (GO:0002275) | 3.36646365 |
| 19 | response to peptidoglycan (GO:0032494) | 3.34741741 |
| 20 | positive regulation of interferon-alpha production (GO:0032727) | 3.33955685 |
| 21 | detection of other organism (GO:0098543) | 3.32901121 |
| 22 | B cell mediated immunity (GO:0019724) | 3.27896211 |
| 23 | positive regulation of type 2 immune response (GO:0002830) | 3.26025408 |
| 24 | macrophage activation (GO:0042116) | 3.23425118 |
| 25 | regulation of chronic inflammatory response (GO:0002676) | 3.23389012 |
| 26 | response to host immune response (GO:0052572) | 3.22356920 |
| 27 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.22356920 |
| 28 | regulation of interferon-alpha production (GO:0032647) | 3.20639614 |
| 29 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.20485468 |
| 30 | granulocyte activation (GO:0036230) | 3.20202522 |
| 31 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.19000585 |
| 32 | regulation of tolerance induction (GO:0002643) | 3.17930228 |
| 33 | detection of bacterium (GO:0016045) | 3.13866033 |
| 34 | positive regulation of tolerance induction (GO:0002645) | 3.10941631 |
| 35 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.10875459 |
| 36 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.10108067 |
| 37 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.10092742 |
| 38 | negative regulation of interleukin-17 production (GO:0032700) | 3.07673751 |
| 39 | positive regulation of antigen processing and presentation (GO:0002579) | 3.06921881 |
| 40 | response to host (GO:0075136) | 3.06788477 |
| 41 | response to host defenses (GO:0052200) | 3.06788477 |
| 42 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.06788477 |
| 43 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.06608617 |
| 44 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.05834696 |
| 45 | neutrophil activation (GO:0042119) | 3.04567714 |
| 46 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.01600812 |
| 47 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.01272013 |
| 48 | B cell receptor signaling pathway (GO:0050853) | 2.99727536 |
| 49 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.97852437 |
| 50 | regulation of regulatory T cell differentiation (GO:0045589) | 2.97808909 |
| 51 | immunoglobulin mediated immune response (GO:0016064) | 2.94987146 |
| 52 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.94928477 |
| 53 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.94928477 |
| 54 | respiratory burst (GO:0045730) | 2.91832148 |
| 55 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.90561646 |
| 56 | defense response to protozoan (GO:0042832) | 2.86871117 |
| 57 | response to muramyl dipeptide (GO:0032495) | 2.86420835 |
| 58 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.85716029 |
| 59 | T cell migration (GO:0072678) | 2.84474244 |
| 60 | leukocyte aggregation (GO:0070486) | 2.83797436 |
| 61 | negative regulation of T cell mediated immunity (GO:0002710) | 2.82375610 |
| 62 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.81112689 |
| 63 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.80784235 |
| 64 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.79657899 |
| 65 | regulation of interleukin-12 production (GO:0032655) | 2.79460318 |
| 66 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.78215273 |
| 67 | response to protozoan (GO:0001562) | 2.77970528 |
| 68 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.76454665 |
| 69 | mast cell activation (GO:0045576) | 2.76072415 |
| 70 | positive regulation of interleukin-17 production (GO:0032740) | 2.75025219 |
| 71 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.74960126 |
| 72 | detection of external biotic stimulus (GO:0098581) | 2.73394461 |
| 73 | regulation of T-helper cell differentiation (GO:0045622) | 2.72982739 |
| 74 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.71835995 |
| 75 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.68542310 |
| 76 | myeloid leukocyte activation (GO:0002274) | 2.68376643 |
| 77 | dendritic cell chemotaxis (GO:0002407) | 2.68162231 |
| 78 | cellular response to interferon-gamma (GO:0071346) | 2.67931921 |
| 79 | regulation of type 2 immune response (GO:0002828) | 2.67831522 |
| 80 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.67160330 |
| 81 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.65326934 |
| 82 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.65216612 |
| 83 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.65043173 |
| 84 | hepatocyte apoptotic process (GO:0097284) | 2.64521646 |
| 85 | dendritic cell migration (GO:0036336) | 2.64181721 |
| 86 | negative thymic T cell selection (GO:0045060) | 2.63580499 |
| 87 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.63518145 |
| 88 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.63090764 |
| 89 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.62927631 |
| 90 | negative T cell selection (GO:0043383) | 2.62282731 |
| 91 | cellular extravasation (GO:0045123) | 2.61975847 |
| 92 | germinal center formation (GO:0002467) | 2.61759819 |
| 93 | positive regulation of interleukin-12 production (GO:0032735) | 2.61172355 |
| 94 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.60981738 |
| 95 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.60789708 |
| 96 | NIK/NF-kappaB signaling (GO:0038061) | 2.59523355 |
| 97 | positive regulation of interleukin-2 production (GO:0032743) | 2.58940299 |
| 98 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.57150384 |
| 99 | regulation of fever generation (GO:0031620) | 2.57146840 |
| 100 | actin nucleation (GO:0045010) | 2.55687913 |
| 101 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.55518997 |
| 102 | positive regulation of interferon-beta production (GO:0032728) | 2.54529862 |
| 103 | myeloid dendritic cell differentiation (GO:0043011) | 2.52535249 |
| 104 | regulation of gamma-delta T cell activation (GO:0046643) | 2.51500995 |
| 105 | regulation of antigen processing and presentation (GO:0002577) | 2.50764500 |
| 106 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.50744429 |
| 107 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.50258699 |
| 108 | myeloid dendritic cell activation (GO:0001773) | 2.49295424 |
| 109 | leukocyte degranulation (GO:0043299) | 2.48133224 |
| 110 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.48059571 |
| 111 | regulation of T cell tolerance induction (GO:0002664) | 2.47323206 |
| 112 | lymphocyte chemotaxis (GO:0048247) | 2.45848321 |
| 113 | positive T cell selection (GO:0043368) | 2.44789538 |
| 114 | positive regulation of macrophage differentiation (GO:0045651) | 2.42763490 |
| 115 | cellular response to zinc ion (GO:0071294) | 2.41433627 |
| 116 | regulation of B cell differentiation (GO:0045577) | 2.41414535 |
| 117 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.40353567 |
| 118 | positive regulation of B cell differentiation (GO:0045579) | 2.39893905 |
| 119 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.39522852 |
| 120 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.39202460 |
| 121 | leukocyte cell-cell adhesion (GO:0007159) | 2.38650519 |
| 122 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.38557357 |
| 123 | positive regulation of mast cell activation (GO:0033005) | 2.37936754 |
| 124 | response to type I interferon (GO:0034340) | 2.37820991 |
| 125 | cellular response to type I interferon (GO:0071357) | 2.37182644 |
| 126 | type I interferon signaling pathway (GO:0060337) | 2.37182644 |
| 127 | regulation of interleukin-17 production (GO:0032660) | 2.36917222 |
| 128 | T cell selection (GO:0045058) | 2.36106337 |
| 129 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.35765916 |
| 130 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.34622455 |
| 131 | positive thymic T cell selection (GO:0045059) | 2.31826983 |
| 132 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.31735293 |
| 133 | T-helper 1 type immune response (GO:0042088) | 2.31279173 |
| 134 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.31214319 |
| 135 | regulation of mononuclear cell migration (GO:0071675) | 2.30688506 |
| 136 | Rap protein signal transduction (GO:0032486) | 2.30152747 |
| 137 | positive regulation of heat generation (GO:0031652) | 2.29860504 |
| 138 | detection of molecule of bacterial origin (GO:0032490) | 2.28532605 |
| 139 | I-kappaB phosphorylation (GO:0007252) | 2.27918285 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.88884220 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.61861704 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.99267298 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.81108691 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.54828319 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.45861303 |
| 7 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.32599937 |
| 8 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.21360554 |
| 9 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.11700571 |
| 10 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.85078365 |
| 11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.81300559 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.73584102 |
| 13 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.70779984 |
| 14 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.64182161 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.60889166 |
| 16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.57570035 |
| 17 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.48879659 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.34064768 |
| 19 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.20813732 |
| 20 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.93937257 |
| 21 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.93921684 |
| 22 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.92674574 |
| 23 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.88185369 |
| 24 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.87339765 |
| 25 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.80701827 |
| 26 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.73037928 |
| 27 | MYB_26560356_Chip-Seq_TH2_Human | 1.69542517 |
| 28 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.65797208 |
| 29 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58554668 |
| 30 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.56148187 |
| 31 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.53380738 |
| 32 | SPI1_23127762_ChIP-Seq_K562_Human | 1.49065066 |
| 33 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.47837979 |
| 34 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.44482864 |
| 35 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.42557034 |
| 36 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.41773771 |
| 37 | TP53_16413492_ChIP-PET_HCT116_Human | 1.41706460 |
| 38 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.40870651 |
| 39 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.40865010 |
| 40 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.40536312 |
| 41 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.38274388 |
| 42 | RXR_22108803_ChIP-Seq_LS180_Human | 1.37690234 |
| 43 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.33606853 |
| 44 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.32673371 |
| 45 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.32016819 |
| 46 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30619183 |
| 47 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.30377897 |
| 48 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.24710606 |
| 49 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.24710606 |
| 50 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.24463405 |
| 51 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.22462041 |
| 52 | MYB_26560356_Chip-Seq_TH1_Human | 1.20705916 |
| 53 | MAF_26560356_Chip-Seq_TH1_Human | 1.19527682 |
| 54 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.19178972 |
| 55 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.18567768 |
| 56 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18485630 |
| 57 | GATA1_22025678_ChIP-Seq_K562_Human | 1.14958149 |
| 58 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.13159504 |
| 59 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.09119825 |
| 60 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.08680835 |
| 61 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08506660 |
| 62 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.07579858 |
| 63 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.06205534 |
| 64 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.05285264 |
| 65 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.05116558 |
| 66 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.03519874 |
| 67 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.02890053 |
| 68 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.02175472 |
| 69 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.01279520 |
| 70 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.01081383 |
| 71 | P300_19829295_ChIP-Seq_ESCs_Human | 1.00956342 |
| 72 | GATA3_26560356_Chip-Seq_TH2_Human | 1.00689247 |
| 73 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.99437421 |
| 74 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.99039107 |
| 75 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.98855074 |
| 76 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97197647 |
| 77 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.97015002 |
| 78 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.96517286 |
| 79 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.96041359 |
| 80 | AR_25329375_ChIP-Seq_VCAP_Human | 0.94751511 |
| 81 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.94512270 |
| 82 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.94508281 |
| 83 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.94468647 |
| 84 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94125458 |
| 85 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.94121593 |
| 86 | CJUN_26792858_Chip-Seq_BT549_Human | 0.93977104 |
| 87 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.93738794 |
| 88 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.93709872 |
| 89 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.93070708 |
| 90 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.92375229 |
| 91 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.91896641 |
| 92 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.91814009 |
| 93 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91805245 |
| 94 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.91527290 |
| 95 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90767722 |
| 96 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.89320616 |
| 97 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88672943 |
| 98 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.88483066 |
| 99 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87117736 |
| 100 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85978668 |
| 101 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.85806106 |
| 102 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.85581417 |
| 103 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.84828966 |
| 104 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.84828966 |
| 105 | GATA2_19941826_ChIP-Seq_K562_Human | 0.84213946 |
| 106 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.83664469 |
| 107 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.83570104 |
| 108 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.83063150 |
| 109 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.82793153 |
| 110 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.82685552 |
| 111 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.81879106 |
| 112 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.80965082 |
| 113 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.80734570 |
| 114 | GATA1_19941826_ChIP-Seq_K562_Human | 0.80050391 |
| 115 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.79963757 |
| 116 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.79477221 |
| 117 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.78817548 |
| 118 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.78266920 |
| 119 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.77964963 |
| 120 | UTX_26944678_Chip-Seq_JUKART_Human | 0.77099809 |
| 121 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.76806215 |
| 122 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.76546098 |
| 123 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.76482006 |
| 124 | * FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.76072313 |
| 125 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.75914524 |
| 126 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.75758806 |
| 127 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.75633331 |
| 128 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.75538303 |
| 129 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.75248937 |
| 130 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.74618004 |
| 131 | GATA3_26560356_Chip-Seq_TH1_Human | 0.73428391 |
| 132 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.73041407 |
| 133 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.72827832 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.73974129 |
| 2 | MP0003303_peritoneal_inflammation | 3.38706525 |
| 3 | MP0003436_decreased_susceptibility_to | 3.14886212 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 2.91503902 |
| 5 | MP0005000_abnormal_immune_tolerance | 2.89264465 |
| 6 | MP0009785_altered_susceptibility_to | 2.69114567 |
| 7 | MP0002419_abnormal_innate_immunity | 2.65757879 |
| 8 | MP0001790_abnormal_immune_system | 2.59235892 |
| 9 | MP0005387_immune_system_phenotype | 2.59235892 |
| 10 | MP0006082_CNS_inflammation | 2.57079978 |
| 11 | MP0005671_abnormal_response_to | 2.55116475 |
| 12 | MP0002452_abnormal_antigen_presenting | 2.45701770 |
| 13 | MP0001800_abnormal_humoral_immune | 2.44391494 |
| 14 | MP0010234_abnormal_vibrissa_follicle | 2.39712839 |
| 15 | MP0000685_abnormal_immune_system | 2.35231539 |
| 16 | MP0003300_gastrointestinal_ulcer | 2.34617688 |
| 17 | MP0005025_abnormal_response_to | 2.27971606 |
| 18 | * MP0002723_abnormal_immune_serum | 2.25382227 |
| 19 | MP0003724_increased_susceptibility_to | 2.22987973 |
| 20 | MP0004859_abnormal_synaptic_plasticity | 2.21086889 |
| 21 | MP0004510_myositis | 2.20804833 |
| 22 | * MP0001819_abnormal_immune_cell | 2.18537735 |
| 23 | * MP0002420_abnormal_adaptive_immunity | 2.18186377 |
| 24 | MP0004947_skin_inflammation | 2.11034477 |
| 25 | MP0005058_abnormal_lysosome_morphology | 2.02763231 |
| 26 | MP0005310_abnormal_salivary_gland | 2.01200304 |
| 27 | MP0000569_abnormal_digit_pigmentation | 1.97533657 |
| 28 | MP0002006_tumorigenesis | 1.94853223 |
| 29 | MP0005464_abnormal_platelet_physiology | 1.90700612 |
| 30 | MP0002166_altered_tumor_susceptibility | 1.85086733 |
| 31 | MP0003075_altered_response_to | 1.83166934 |
| 32 | MP0001533_abnormal_skeleton_physiology | 1.78374389 |
| 33 | MP0003172_abnormal_lysosome_physiology | 1.71249745 |
| 34 | MP0003183_abnormal_peptide_metabolism | 1.67812411 |
| 35 | MP0002405_respiratory_system_inflammati | 1.67281763 |
| 36 | MP0002254_reproductive_system_inflammat | 1.66045924 |
| 37 | MP0000604_amyloidosis | 1.61349674 |
| 38 | MP0010155_abnormal_intestine_physiology | 1.58676459 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.53687117 |
| 40 | * MP0002398_abnormal_bone_marrow | 1.52479649 |
| 41 | MP0005076_abnormal_cell_differentiation | 1.51585764 |
| 42 | * MP0000716_abnormal_immune_system | 1.50191706 |
| 43 | MP0003448_altered_tumor_morphology | 1.44888421 |
| 44 | MP0003763_abnormal_thymus_physiology | 1.42908828 |
| 45 | MP0001853_heart_inflammation | 1.41797836 |
| 46 | MP0005166_decreased_susceptibility_to | 1.39431407 |
| 47 | MP0002998_abnormal_bone_remodeling | 1.39070927 |
| 48 | MP0008004_abnormal_stomach_pH | 1.36644698 |
| 49 | MP0003656_abnormal_erythrocyte_physiolo | 1.34944709 |
| 50 | MP0003880_abnormal_central_pattern | 1.34578459 |
| 51 | MP0000858_altered_metastatic_potential | 1.33176209 |
| 52 | MP0005174_abnormal_tail_pigmentation | 1.30962981 |
| 53 | MP0009764_decreased_sensitivity_to | 1.30018788 |
| 54 | MP0001873_stomach_inflammation | 1.28124951 |
| 55 | MP0009840_abnormal_foam_cell | 1.26112352 |
| 56 | MP0001851_eye_inflammation | 1.23863470 |
| 57 | MP0003806_abnormal_nucleotide_metabolis | 1.23401441 |
| 58 | MP0000465_gastrointestinal_hemorrhage | 1.23070999 |
| 59 | MP0001501_abnormal_sleep_pattern | 1.22562770 |
| 60 | MP0003091_abnormal_cell_migration | 1.21461289 |
| 61 | MP0000689_abnormal_spleen_morphology | 1.18102863 |
| 62 | MP0002877_abnormal_melanocyte_morpholog | 1.16815983 |
| 63 | MP0005167_abnormal_blood-brain_barrier | 1.16563761 |
| 64 | MP0005397_hematopoietic_system_phenotyp | 1.12390934 |
| 65 | MP0001545_abnormal_hematopoietic_system | 1.12390934 |
| 66 | MP0003045_fibrosis | 1.11930914 |
| 67 | MP0002722_abnormal_immune_system | 1.10317087 |
| 68 | MP0002009_preneoplasia | 1.10206836 |
| 69 | * MP0002429_abnormal_blood_cell | 1.09594723 |
| 70 | MP0009763_increased_sensitivity_to | 1.09262374 |
| 71 | MP0000343_altered_response_to | 1.08413677 |
| 72 | MP0003635_abnormal_synaptic_transmissio | 1.06141944 |
| 73 | MP0003690_abnormal_glial_cell | 1.04131385 |
| 74 | MP0009278_abnormal_bone_marrow | 1.03921259 |
| 75 | MP0002139_abnormal_hepatobiliary_system | 1.03856088 |
| 76 | MP0008469_abnormal_protein_level | 1.02242917 |
| 77 | MP0009765_abnormal_xenobiotic_induced | 1.01144036 |
| 78 | MP0005164_abnormal_response_to | 0.99789796 |
| 79 | MP0003866_abnormal_defecation | 0.99699185 |
| 80 | MP0008260_abnormal_autophagy | 0.99542588 |
| 81 | MP0009333_abnormal_splenocyte_physiolog | 0.99453781 |
| 82 | MP0002063_abnormal_learning/memory/cond | 0.99170823 |
| 83 | MP0001440_abnormal_grooming_behavior | 0.98248774 |
| 84 | MP0003453_abnormal_keratinocyte_physiol | 0.96354028 |
| 85 | MP0003191_abnormal_cellular_cholesterol | 0.94230491 |
| 86 | MP0004185_abnormal_adipocyte_glucose | 0.92285180 |
| 87 | MP0000015_abnormal_ear_pigmentation | 0.92257048 |
| 88 | MP0002332_abnormal_exercise_endurance | 0.91650678 |
| 89 | MP0005084_abnormal_gallbladder_morpholo | 0.90895347 |
| 90 | MP0009745_abnormal_behavioral_response | 0.89290707 |
| 91 | MP0003828_pulmonary_edema | 0.89276701 |
| 92 | MP0003329_amyloid_beta_deposits | 0.88393726 |
| 93 | MP0010678_abnormal_skin_adnexa | 0.87711538 |
| 94 | MP0003566_abnormal_cell_adhesion | 0.82649965 |
| 95 | MP0002933_joint_inflammation | 0.81278991 |
| 96 | MP0005075_abnormal_melanosome_morpholog | 0.80573315 |
| 97 | MP0004883_abnormal_blood_vessel | 0.80267024 |
| 98 | MP0000703_abnormal_thymus_morphology | 0.79625121 |
| 99 | MP0002138_abnormal_hepatobiliary_system | 0.79378416 |
| 100 | MP0001663_abnormal_digestive_system | 0.78790814 |
| 101 | MP0005390_skeleton_phenotype | 0.78431547 |
| 102 | MP0002277_abnormal_respiratory_mucosa | 0.76145130 |
| 103 | MP0005171_absent_coat_pigmentation | 0.75669954 |
| 104 | MP0002064_seizures | 0.75042536 |
| 105 | MP0005165_increased_susceptibility_to | 0.74454446 |
| 106 | MP0002736_abnormal_nociception_after | 0.72436234 |
| 107 | MP0000249_abnormal_blood_vessel | 0.72228057 |
| 108 | MP0006054_spinal_hemorrhage | 0.70919453 |
| 109 | MP0001191_abnormal_skin_condition | 0.70505128 |
| 110 | MP0004808_abnormal_hematopoietic_stem | 0.70023095 |
| 111 | MP0001216_abnormal_epidermal_layer | 0.69868812 |
| 112 | MP0000920_abnormal_myelination | 0.68696189 |
| 113 | MP0003795_abnormal_bone_structure | 0.67138711 |
| 114 | MP0003195_calcinosis | 0.67040788 |
| 115 | MP0010307_abnormal_tumor_latency | 0.66689152 |
| 116 | MP0008961_abnormal_basal_metabolism | 0.64983592 |
| 117 | MP0008874_decreased_physiological_sensi | 0.64850385 |
| 118 | MP0010352_gastrointestinal_tract_polyps | 0.59132112 |
| 119 | MP0001542_abnormal_bone_strength | 0.58806098 |
| 120 | MP0002796_impaired_skin_barrier | 0.58146771 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.61869977 |
| 2 | Recurrent abscess formation (HP:0002722) | 5.41518787 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.81502555 |
| 4 | Increased cerebral lipofuscin (HP:0011813) | 3.91220186 |
| 5 | Mediastinal lymphadenopathy (HP:0100721) | 3.69362060 |
| 6 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.68531849 |
| 7 | Myositis (HP:0100614) | 3.68517068 |
| 8 | Retrobulbar optic neuritis (HP:0100654) | 3.65323568 |
| 9 | Optic neuritis (HP:0100653) | 3.65323568 |
| 10 | Abnormality of macrophages (HP:0004311) | 3.62973461 |
| 11 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.61358641 |
| 12 | Orchitis (HP:0100796) | 3.60636363 |
| 13 | Disinhibition (HP:0000734) | 3.41409750 |
| 14 | Recurrent fungal infections (HP:0002841) | 3.35195789 |
| 15 | Stomatitis (HP:0010280) | 3.23837174 |
| 16 | Vacuolated lymphocytes (HP:0001922) | 3.16903216 |
| 17 | Recurrent viral infections (HP:0004429) | 3.08256431 |
| 18 | Encephalitis (HP:0002383) | 3.04407601 |
| 19 | Hematochezia (HP:0002573) | 2.94106620 |
| 20 | Gangrene (HP:0100758) | 2.93670951 |
| 21 | Recurrent skin infections (HP:0001581) | 2.91111507 |
| 22 | Autoimmune thrombocytopenia (HP:0001973) | 2.89194961 |
| 23 | Vasculitis (HP:0002633) | 2.87668733 |
| 24 | Petechiae (HP:0000967) | 2.82283345 |
| 25 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.80785530 |
| 26 | Thick nail (HP:0001805) | 2.78711884 |
| 27 | Chronic obstructive pulmonary disease (HP:0006510) | 2.78176277 |
| 28 | Obstructive lung disease (HP:0006536) | 2.78176277 |
| 29 | Keratoconjunctivitis sicca (HP:0001097) | 2.77818981 |
| 30 | Loss of speech (HP:0002371) | 2.77534680 |
| 31 | Cellulitis (HP:0100658) | 2.75536579 |
| 32 | Pustule (HP:0200039) | 2.74609545 |
| 33 | Prolonged bleeding time (HP:0003010) | 2.74166681 |
| 34 | Gingivitis (HP:0000230) | 2.73476288 |
| 35 | Dysostosis multiplex (HP:0000943) | 2.72264984 |
| 36 | Pulmonary infiltrates (HP:0002113) | 2.67455037 |
| 37 | Chronic otitis media (HP:0000389) | 2.66814015 |
| 38 | Arterial thrombosis (HP:0004420) | 2.62871629 |
| 39 | Gastrointestinal infarctions (HP:0005244) | 2.62705395 |
| 40 | Systemic lupus erythematosus (HP:0002725) | 2.58815570 |
| 41 | Abnormality of T cell number (HP:0011839) | 2.56693783 |
| 42 | Inappropriate behavior (HP:0000719) | 2.53963419 |
| 43 | Periodontitis (HP:0000704) | 2.53564388 |
| 44 | Focal motor seizures (HP:0011153) | 2.53321903 |
| 45 | Meningitis (HP:0001287) | 2.52698211 |
| 46 | Arterial tortuosity (HP:0005116) | 2.52507726 |
| 47 | Increased IgE level (HP:0003212) | 2.51287898 |
| 48 | Epistaxis (HP:0000421) | 2.48926238 |
| 49 | Keratoconjunctivitis (HP:0001096) | 2.48125239 |
| 50 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.42672844 |
| 51 | Recurrent cutaneous fungal infections (HP:0011370) | 2.42672844 |
| 52 | Abnormality of the prostate (HP:0008775) | 2.42168047 |
| 53 | Abnormality of glycolipid metabolism (HP:0010969) | 2.40199417 |
| 54 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.40199417 |
| 55 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.40199417 |
| 56 | Abnormality of B cell number (HP:0010975) | 2.37912801 |
| 57 | Absent frontal sinuses (HP:0002688) | 2.37604147 |
| 58 | Polyneuropathy (HP:0001271) | 2.36623276 |
| 59 | T lymphocytopenia (HP:0005403) | 2.36164486 |
| 60 | Purpura (HP:0000979) | 2.35450517 |
| 61 | Gingival bleeding (HP:0000225) | 2.35243981 |
| 62 | Joint swelling (HP:0001386) | 2.35098468 |
| 63 | Agammaglobulinemia (HP:0004432) | 2.32930861 |
| 64 | Recurrent bronchitis (HP:0002837) | 2.32022099 |
| 65 | IgG deficiency (HP:0004315) | 2.28793789 |
| 66 | Pulmonary embolism (HP:0002204) | 2.27996845 |
| 67 | Vascular tortuosity (HP:0004948) | 2.27061092 |
| 68 | Osteomyelitis (HP:0002754) | 2.26557915 |
| 69 | Chest pain (HP:0100749) | 2.25612518 |
| 70 | Chronic diarrhea (HP:0002028) | 2.25462911 |
| 71 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.25248589 |
| 72 | Colitis (HP:0002583) | 2.24254965 |
| 73 | Diminished motivation (HP:0000745) | 2.22437832 |
| 74 | Apathy (HP:0000741) | 2.22026879 |
| 75 | Increased IgM level (HP:0003496) | 2.19803281 |
| 76 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.19526122 |
| 77 | Interstitial pulmonary disease (HP:0006530) | 2.19033101 |
| 78 | Autoimmune hemolytic anemia (HP:0001890) | 2.18994686 |
| 79 | Agnosia (HP:0010524) | 2.17510163 |
| 80 | Anorexia (HP:0002039) | 2.16788493 |
| 81 | Abnormality of binocular vision (HP:0011514) | 2.14274854 |
| 82 | Diplopia (HP:0000651) | 2.14274854 |
| 83 | B lymphocytopenia (HP:0010976) | 2.13898170 |
| 84 | Abnormality of the pleura (HP:0002103) | 2.12818804 |
| 85 | Premature loss of primary teeth (HP:0006323) | 2.12476601 |
| 86 | Alveolar cell carcinoma (HP:0006519) | 2.12291095 |
| 87 | Inflammation of the large intestine (HP:0002037) | 2.10321927 |
| 88 | Eosinophilia (HP:0001880) | 2.09220627 |
| 89 | Abnormality of eosinophils (HP:0001879) | 2.09124096 |
| 90 | Increased CSF protein (HP:0002922) | 2.08720816 |
| 91 | Stomach cancer (HP:0012126) | 2.08644971 |
| 92 | Thyroiditis (HP:0100646) | 2.08586051 |
| 93 | Hepatosplenomegaly (HP:0001433) | 2.07974190 |
| 94 | Spondylolisthesis (HP:0003302) | 2.07671320 |
| 95 | Leukocytosis (HP:0001974) | 2.07662387 |
| 96 | Severe combined immunodeficiency (HP:0004430) | 2.07508031 |
| 97 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.06339191 |
| 98 | Mucopolysacchariduria (HP:0008155) | 2.06339191 |
| 99 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.05026825 |
| 100 | Parakeratosis (HP:0001036) | 2.04489939 |
| 101 | Spontaneous hematomas (HP:0007420) | 2.04440582 |
| 102 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.04365261 |
| 103 | Gastrointestinal stroma tumor (HP:0100723) | 2.04299188 |
| 104 | Panhypogammaglobulinemia (HP:0003139) | 2.03539470 |
| 105 | Cerebral inclusion bodies (HP:0100314) | 2.01652048 |
| 106 | Granulocytopenia (HP:0001913) | 2.01646150 |
| 107 | Mutism (HP:0002300) | 2.01472102 |
| 108 | Hypergammaglobulinemia (HP:0010702) | 2.01311723 |
| 109 | Myocardial infarction (HP:0001658) | 2.01168515 |
| 110 | Osteolytic defects of the hand bones (HP:0009699) | 2.00893127 |
| 111 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.00893127 |
| 112 | Axonal loss (HP:0003447) | 1.99722331 |
| 113 | Prostate neoplasm (HP:0100787) | 1.98990645 |
| 114 | Papilledema (HP:0001085) | 1.98194067 |
| 115 | Sepsis (HP:0100806) | 1.98147759 |
| 116 | Urticaria (HP:0001025) | 1.95560387 |
| 117 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.95208623 |
| 118 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.95208623 |
| 119 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.95208623 |
| 120 | Gastrointestinal inflammation (HP:0004386) | 1.93741309 |
| 121 | Abnormality of T cells (HP:0002843) | 1.93305758 |
| 122 | Fatigue (HP:0012378) | 1.93067186 |
| 123 | Erythema (HP:0010783) | 1.92968787 |
| 124 | Neurofibrillary tangles (HP:0002185) | 1.92908194 |
| 125 | Visual hallucinations (HP:0002367) | 1.90952403 |
| 126 | Combined immunodeficiency (HP:0005387) | 1.90784970 |
| 127 | Hemoptysis (HP:0002105) | 1.90473169 |
| 128 | Glomerulonephritis (HP:0000099) | 1.90218703 |
| 129 | Amaurosis fugax (HP:0100576) | 1.88573646 |
| 130 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.88389662 |
| 131 | Lymphopenia (HP:0001888) | 1.88359590 |
| 132 | Glomerulopathy (HP:0100820) | 1.87130803 |
| 133 | Episodic fever (HP:0001954) | 1.85458118 |
| 134 | Vertigo (HP:0002321) | 1.85453838 |
| 135 | Recurrent pneumonia (HP:0006532) | 1.84353909 |
| 136 | Basal ganglia calcification (HP:0002135) | 1.83298924 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 5.56069673 |
| 2 | MAP3K14 | 3.22337049 |
| 3 | MAP3K13 | 3.03822644 |
| 4 | MAP3K12 | 2.56277923 |
| 5 | BLK | 2.45980755 |
| 6 | TBK1 | 2.35900044 |
| 7 | TXK | 2.22420881 |
| 8 | IRAK4 | 2.21419772 |
| 9 | MAP4K1 | 2.15464526 |
| 10 | TYK2 | 2.07465999 |
| 11 | BMPR2 | 2.00355979 |
| 12 | EPHA4 | 1.99480066 |
| 13 | SIK3 | 1.97435712 |
| 14 | IKBKE | 1.97069854 |
| 15 | JAK3 | 1.84558173 |
| 16 | FES | 1.79542710 |
| 17 | STK10 | 1.78744920 |
| 18 | ACVR1B | 1.78289367 |
| 19 | SIK2 | 1.77227261 |
| 20 | TGFBR2 | 1.75372405 |
| 21 | IRAK3 | 1.75162779 |
| 22 | MAP3K9 | 1.74276076 |
| 23 | EIF2AK3 | 1.70960944 |
| 24 | PLK2 | 1.68570870 |
| 25 | SYK | 1.62851323 |
| 26 | JAK1 | 1.57708492 |
| 27 | MST4 | 1.57674108 |
| 28 | STK24 | 1.54970510 |
| 29 | GRK6 | 1.46795598 |
| 30 | FGR | 1.46033305 |
| 31 | KIT | 1.36076312 |
| 32 | IRAK1 | 1.34704707 |
| 33 | ZAP70 | 1.32265435 |
| 34 | HCK | 1.30114576 |
| 35 | NTRK3 | 1.29975200 |
| 36 | KSR2 | 1.29894552 |
| 37 | IKBKB | 1.29668105 |
| 38 | MAP3K3 | 1.28298991 |
| 39 | ITK | 1.27165249 |
| 40 | CSK | 1.26161988 |
| 41 | ADRBK2 | 1.19821926 |
| 42 | FGFR3 | 1.17886765 |
| 43 | LCK | 1.08079476 |
| 44 | MAP3K2 | 1.07524781 |
| 45 | IRAK2 | 1.06914070 |
| 46 | MAP4K2 | 1.06362542 |
| 47 | CLK1 | 1.06171705 |
| 48 | PRKCQ | 1.03634051 |
| 49 | LYN | 0.98187767 |
| 50 | MAP2K3 | 0.97075217 |
| 51 | NEK9 | 0.96302177 |
| 52 | TNK2 | 0.93323508 |
| 53 | TEC | 0.92479048 |
| 54 | RAF1 | 0.92180136 |
| 55 | DAPK1 | 0.90424251 |
| 56 | TAOK2 | 0.89762871 |
| 57 | KSR1 | 0.89521227 |
| 58 | CHUK | 0.87939047 |
| 59 | MARK3 | 0.87684385 |
| 60 | ARAF | 0.86751691 |
| 61 | PIK3CG | 0.86617145 |
| 62 | LRRK2 | 0.86352233 |
| 63 | FRK | 0.84056284 |
| 64 | JAK2 | 0.83733862 |
| 65 | MOS | 0.82688265 |
| 66 | DAPK2 | 0.81955868 |
| 67 | PTK2B | 0.80936779 |
| 68 | TAOK1 | 0.79126245 |
| 69 | PRPF4B | 0.77714376 |
| 70 | MAPKAPK3 | 0.77201206 |
| 71 | MST1R | 0.76159177 |
| 72 | PINK1 | 0.72933021 |
| 73 | CSF1R | 0.72259624 |
| 74 | GRK7 | 0.70744269 |
| 75 | ERBB3 | 0.70406951 |
| 76 | TAOK3 | 0.69114163 |
| 77 | BTK | 0.68738074 |
| 78 | MATK | 0.67455242 |
| 79 | GRK5 | 0.67168096 |
| 80 | EGFR | 0.64735891 |
| 81 | MAP3K1 | 0.64531712 |
| 82 | MAP2K6 | 0.63605608 |
| 83 | TESK2 | 0.63251416 |
| 84 | RIPK1 | 0.62388367 |
| 85 | FYN | 0.62100594 |
| 86 | MAPK7 | 0.62020637 |
| 87 | PDK1 | 0.57211287 |
| 88 | NUAK1 | 0.56790500 |
| 89 | CAMKK1 | 0.56674962 |
| 90 | ERN1 | 0.56226657 |
| 91 | TRIM28 | 0.55757582 |
| 92 | BCR | 0.53810975 |
| 93 | CDK6 | 0.53207373 |
| 94 | MAP3K5 | 0.51780809 |
| 95 | NLK | 0.51287212 |
| 96 | TRPM7 | 0.50842675 |
| 97 | DDR2 | 0.50545959 |
| 98 | TNIK | 0.49140752 |
| 99 | CDK9 | 0.48987624 |
| 100 | EPHA3 | 0.48152489 |
| 101 | PRKCD | 0.47929050 |
| 102 | PRKCH | 0.47835979 |
| 103 | PDGFRB | 0.47325418 |
| 104 | PIM1 | 0.46073257 |
| 105 | CAMKK2 | 0.45552711 |
| 106 | RET | 0.45045250 |
| 107 | CDK5 | 0.43385475 |
| 108 | EPHB1 | 0.42888948 |
| 109 | * ABL1 | 0.42502979 |
| 110 | IGF1R | 0.42355412 |
| 111 | OXSR1 | 0.41616041 |
| 112 | FER | 0.41219696 |
| 113 | EIF2AK2 | 0.38990318 |
| 114 | PIM2 | 0.38976073 |
| 115 | YES1 | 0.38955181 |
| 116 | PTK6 | 0.38645262 |
| 117 | RPS6KA4 | 0.38419773 |
| 118 | SGK3 | 0.38329562 |
| 119 | DMPK | 0.37391216 |
| 120 | PRKCE | 0.36656814 |
| 121 | SCYL2 | 0.36503877 |
| 122 | BMX | 0.36135295 |
| 123 | SGK1 | 0.35063859 |
| 124 | NTRK2 | 0.34378355 |
| 125 | MAP3K11 | 0.34361570 |
| 126 | BMPR1B | 0.34253010 |
| 127 | SGK2 | 0.34109113 |
| 128 | INSR | 0.34053701 |
| 129 | MAP2K7 | 0.33976244 |
| 130 | FGFR4 | 0.33789824 |
| 131 | STK3 | 0.32320536 |
| 132 | TESK1 | 0.30863705 |
| 133 | MAPKAPK2 | 0.30116372 |
| 134 | TGFBR1 | 0.29931275 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.35279822 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.14214057 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.87640532 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.79535074 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.78456010 |
| 6 | Tuberculosis_Homo sapiens_hsa05152 | 1.77248088 |
| 7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.76873149 |
| 8 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.73685951 |
| 9 | Pertussis_Homo sapiens_hsa05133 | 1.62170095 |
| 10 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.57706794 |
| 11 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.52102687 |
| 12 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.51121986 |
| 13 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.49049806 |
| 14 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.46959636 |
| 15 | Salmonella infection_Homo sapiens_hsa05132 | 1.46066941 |
| 16 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.42442039 |
| 17 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.42303196 |
| 18 | Allograft rejection_Homo sapiens_hsa05330 | 1.41299624 |
| 19 | Measles_Homo sapiens_hsa05162 | 1.41090307 |
| 20 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.40864561 |
| 21 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.40149465 |
| 22 | Long-term potentiation_Homo sapiens_hsa04720 | 1.39418313 |
| 23 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.37663128 |
| 24 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.37596663 |
| 25 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.37160960 |
| 26 | Shigellosis_Homo sapiens_hsa05131 | 1.35331739 |
| 27 | Legionellosis_Homo sapiens_hsa05134 | 1.32799961 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.32370737 |
| 29 | Malaria_Homo sapiens_hsa05144 | 1.32016168 |
| 30 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.26668844 |
| 31 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.23227658 |
| 32 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.23195089 |
| 33 | Phagosome_Homo sapiens_hsa04145 | 1.20153440 |
| 34 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.19657238 |
| 35 | Influenza A_Homo sapiens_hsa05164 | 1.17906393 |
| 36 | Lysosome_Homo sapiens_hsa04142 | 1.14280661 |
| 37 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.13503716 |
| 38 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.12695654 |
| 39 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.08884654 |
| 40 | Hepatitis B_Homo sapiens_hsa05161 | 1.06804841 |
| 41 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.05244431 |
| 42 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.02836360 |
| 43 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.02455527 |
| 44 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.00024692 |
| 45 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.98977190 |
| 46 | Olfactory transduction_Homo sapiens_hsa04740 | 0.96678253 |
| 47 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.96587666 |
| 48 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.96113383 |
| 49 | Platelet activation_Homo sapiens_hsa04611 | 0.95744734 |
| 50 | Nicotine addiction_Homo sapiens_hsa05033 | 0.95653295 |
| 51 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.94917232 |
| 52 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.94444618 |
| 53 | Salivary secretion_Homo sapiens_hsa04970 | 0.93726764 |
| 54 | Apoptosis_Homo sapiens_hsa04210 | 0.90027393 |
| 55 | Renin secretion_Homo sapiens_hsa04924 | 0.89696793 |
| 56 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.89476005 |
| 57 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.88741211 |
| 58 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.88077225 |
| 59 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.86377608 |
| 60 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.86014739 |
| 61 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.84496479 |
| 62 | Glioma_Homo sapiens_hsa05214 | 0.83917421 |
| 63 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.83353108 |
| 64 | Long-term depression_Homo sapiens_hsa04730 | 0.81216690 |
| 65 | Amoebiasis_Homo sapiens_hsa05146 | 0.80926757 |
| 66 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.80732430 |
| 67 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.80502684 |
| 68 | Hepatitis C_Homo sapiens_hsa05160 | 0.79708882 |
| 69 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.79665553 |
| 70 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.79604458 |
| 71 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.79380639 |
| 72 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.79205623 |
| 73 | Morphine addiction_Homo sapiens_hsa05032 | 0.78528620 |
| 74 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.78517083 |
| 75 | Viral myocarditis_Homo sapiens_hsa05416 | 0.77759397 |
| 76 | Asthma_Homo sapiens_hsa05310 | 0.77484170 |
| 77 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.77262059 |
| 78 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.75479020 |
| 79 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.74894743 |
| 80 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.73307345 |
| 81 | Circadian entrainment_Homo sapiens_hsa04713 | 0.72907986 |
| 82 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.71673693 |
| 83 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.70770286 |
| 84 | Endocytosis_Homo sapiens_hsa04144 | 0.69527828 |
| 85 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.68876998 |
| 86 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.68607866 |
| 87 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.67817992 |
| 88 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.65863303 |
| 89 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.64142904 |
| 90 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.64102881 |
| 91 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.63773472 |
| 92 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.63655368 |
| 93 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.63651845 |
| 94 | Other glycan degradation_Homo sapiens_hsa00511 | 0.62319896 |
| 95 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.62200177 |
| 96 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.61809994 |
| 97 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.61014693 |
| 98 | Adherens junction_Homo sapiens_hsa04520 | 0.59955114 |
| 99 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.58299202 |
| 100 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.58149429 |
| 101 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.58090537 |
| 102 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.57911690 |
| 103 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.57530167 |
| 104 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.57529180 |
| 105 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.54108721 |
| 106 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.42496371 |
| 107 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.41377859 |
| 108 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.38525206 |
| 109 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.34448594 |
| 110 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.33680370 |
| 111 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.32590667 |
| 112 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.31340427 |
| 113 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.30161604 |
| 114 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.29128408 |
| 115 | HTLV-I infection_Homo sapiens_hsa05166 | 0.27884416 |
| 116 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.25124206 |
| 117 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.22862688 |
| 118 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.22262950 |
| 119 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.21421545 |
| 120 | Mineral absorption_Homo sapiens_hsa04978 | 0.20046568 |
| 121 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.17873557 |
| 122 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.17554561 |
| 123 | Circadian rhythm_Homo sapiens_hsa04710 | 0.15306214 |
| 124 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.14537198 |
| 125 | Peroxisome_Homo sapiens_hsa04146 | 0.14307981 |
| 126 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.12796483 |
| 127 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.12115469 |
| 128 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.12080637 |
| 129 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.11579079 |
| 130 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.10046630 |

